ifosfamide has been researched along with Animal Mammary Carcinoma in 3 studies
Excerpt | Relevance | Reference |
---|---|---|
" The seven agents combined with CI-973 were mitomycin C, cyclophosphamide, doxorubicin, vinblastine, etoposide, ifosfamide, and methotrexate." | 1.29 | Chemotherapy with [SP-4-3-(R)]-[1,1-cyclobutanedicarboxylato(2-)](2- methyl-1,4-butanediamine-N,N')platinum (CI-973, NK121) in combination with standard agents against murine tumors in vivo. ( Elliott, WL; Howard, CT; Leopold, WR; Roberts, BJ, 1994) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 3 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Elliott, WL | 1 |
Roberts, BJ | 1 |
Howard, CT | 1 |
Leopold, WR | 1 |
Teicher, BA | 1 |
Holden, SA | 1 |
Goff, DA | 1 |
Wright, JE | 1 |
Tretyakov, O | 1 |
Ayash, LJ | 1 |
Rodrigues, LM | 1 |
Maxwell, RJ | 1 |
McSheehy, PM | 1 |
Pinkerton, CR | 1 |
Robinson, SP | 1 |
Stubbs, M | 1 |
Griffiths, JR | 1 |
3 other studies available for ifosfamide and Animal Mammary Carcinoma
Article | Year |
---|---|
Chemotherapy with [SP-4-3-(R)]-[1,1-cyclobutanedicarboxylato(2-)](2- methyl-1,4-butanediamine-N,N')platinum (CI-973, NK121) in combination with standard agents against murine tumors in vivo.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Colonic Neoplasms; Cyclophosph | 1994 |
Antitumor efficacy and pharmacokinetic analysis of 4-hydroperoxycyclophosphamide in comparison with cyclophosphamide +/- hepatic enzyme effectors.
Topics: Adenocarcinoma; Animals; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Pro | 1996 |
In vivo detection of ifosfamide by 31P-MRS in rat tumours: increased uptake and cytotoxicity induced by carbogen breathing in GH3 prolactinomas.
Topics: Animals; Antineoplastic Agents, Alkylating; Carbon Dioxide; Cell Count; Cell Survival; Female; Ifosf | 1997 |